{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:17:57Z","timestamp":1793661477641,"version":"4.5.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.eururo.2015.06.012","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:18:17Z","timestamp":1435846697000},"page":"814-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers"],"prefix":"10.1016","volume":"68","author":[{"given":"Leonard P.","family":"Bokhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnout R.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valdagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris H.","family":"Bangma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2015.06.012_bib0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.eururo.2012.11.005","article-title":"Active surveillance for low-risk prostate cancer worldwide: the PRIAS study","volume":"63","author":"Bul","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0100","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1200\/JCO.2010.32.8112","article-title":"Active surveillance program for prostate cancer: an update of the Johns Hopkins experience","volume":"29","author":"Tosoian","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2010.08.027","article-title":"Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment","volume":"58","author":"Soloway","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.02.020","article-title":"Medium-term outcomes of active surveillance for localised prostate cancer","volume":"64","author":"Selvadurai","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.2010.31.4252","article-title":"Outcomes of active surveillance for men with intermediate-risk prostate cancer","volume":"29","author":"Cooperberg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0125","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.eururo.2007.05.011","article-title":"Prospective validation of active surveillance in prostate cancer: the PRIAS study","volume":"52","author":"van den Bergh","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0130","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1016\/j.juro.2015.02.2240","article-title":"Frequency of PSA testing in men on active surveillance for prostate cancer","volume":"193","author":"Bokhorst","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0135","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol."},{"key":"10.1016\/j.eururo.2015.06.012_bib0140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0090-4295(02)01864-2","article-title":"Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study","volume":"60","author":"Mkinen","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2015.06.012_bib0145","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.juro.2014.09.094","article-title":"Extended follow-up and risk factors for disease reclassification from a large active surveillance cohort for localized prostate cancer","volume":"193","author":"Welty","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bju.12828","article-title":"Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and PRIAS protocols","volume":"115","author":"Kates","year":"2015","journal-title":"BJU Int."},{"key":"10.1016\/j.eururo.2015.06.012_bib0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.eururo.2011.06.027","article-title":"Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program","volume":"61","author":"Bul","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","article-title":"Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review","volume":"67","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0165","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2009.25.7311","article-title":"Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program","volume":"28","author":"Ross","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2012.02.002","article-title":"Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study","volume":"62","author":"Bul","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.06.012_bib0175","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bju.12879","article-title":"Disease-specific death and metastasis do not occur in patients with Gleason score \u22646 on radical prostatectomy","volume":"116","author":"Kweldam","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2015.06.012_bib0180","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score (GS) \u22646 have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross","year":"2012","journal-title":"Am J Surg Pathol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283815005151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283815005151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T02:26:57Z","timestamp":1537496817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283815005151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0302283815005151"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2015.06.012","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2015.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}